CDXS multibagger in the worksNASDAQ:CDXS
Chart looks epic. Looking for 8.50 over the next year. Massive weekly volume and eye turning form 4s.
www.tradingview.com
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.88 USD
−76.24 M USD
70.14 M USD
79.18 M
About Codexis, Inc.
Sector
CEO
Stephen George Dilly
Headquarters
Redwood City
Website
Founded
2002
FIGI
BBG000RN0GZ5
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
CDXS Poised to go upwardI believe what I see numbers and charts! looks bullish to me. Please give some endorsement and it will motivates me to work hard!
Good luck
Promising Long Trade OpportunityHello, traders! Today, I am excited to present a highly promising long trade opportunity that revolves around a bullish order block at $2.29. This trade offers an attractive risk-reward ratio, with a focus on targeting equal highs and capturing potential upward momentum.
Based on careful analysis,
Long Term Buy -(CDXS) Trend Reversal on the Horizon!Today, we're turning our spotlight on Codexis, Inc. (CDXS), a leader in protein engineering. We've been closely observing CDXS and see a potentially exciting opportunity unfolding, and we thought it would be a great time to share our thoughts with you.
Our analysis reveals that CDXS is currently sh
CDXS - upcoming catalystThis is not a financial advice!
Most info on the chart.
Price is at resistance.
We might seeing a pullback first before continuing or we need to break 7 for confirmation. Addtionlly there is a gap.
Trade carefully!
CDXS: Ascending Triangle (64%)Codexis brogr through the 28,80$ resistance once again. This time, it may actually stay above.
Resistance could become support.
Ascending triangle, confirmed!
Price Target = 47.44$
Stay humble, have fun, make money!
CDXS short worked out today 3.8 R3.8 times the initial risk gained on a 5 min breakdown of the 3rd biggest pre-market gainer
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CDXS is 5.00 USD — it has increased by 1.42% in the past 24 hours. Watch Codexis, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Codexis, Inc. stocks are traded under the ticker CDXS.
CDXS stock has fallen by −10.23% compared to the previous week, the month change is a 14.42% rise, over the last year Codexis, Inc. has showed a 62.87% increase.
We've gathered analysts' opinions on Codexis, Inc. future price: according to them, CDXS price has a max estimate of 11.00 USD and a min estimate of 3.00 USD. Watch CDXS chart and read a more detailed Codexis, Inc. stock forecast: see what analysts think of Codexis, Inc. and suggest that you do with its stocks.
CDXS reached its all-time high on Nov 8, 2021 with the price of 42.01 USD, and its all-time low was 1.24 USD and was reached on Dec 24, 2013. View more price dynamics on CDXS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CDXS stock is 3.72% volatile and has beta coefficient of 1.45. Track Codexis, Inc. stock price on the chart and check out the list of the most volatile stocks — is Codexis, Inc. there?
Today Codexis, Inc. has the market capitalization of 406.89 M, it has decreased by −12.43% over the last week.
Yes, you can track Codexis, Inc. financials in yearly and quarterly reports right on TradingView.
Codexis, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CDXS earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.24 USD resulting in a −21.47% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Codexis, Inc. earnings.
Codexis, Inc. revenue for the last quarter amounts to 12.83 M USD, despite the estimated figure of 11.49 M USD. In the next quarter, revenue is expected to reach 27.41 M USD.
CDXS net income for the last quarter is −20.64 M USD, while the quarter before that showed −22.75 M USD of net income which accounts for 9.29% change. Track more Codexis, Inc. financial stats to get the full picture.
No, CDXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 174.00 employees. See our rating of the largest employees — is Codexis, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Codexis, Inc. EBITDA is −42.72 M USD, and current EBITDA margin is −63.98%. See more stats in Codexis, Inc. financial statements.
Like other stocks, CDXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Codexis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Codexis, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Codexis, Inc. stock shows the neutral signal. See more of Codexis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.